Unknown PHASE3 INTERVENTIONAL 2-arm NCT01498029

Knee Articular Cartilage Repair: Cartilage Autograft Implantation System Versus Conventional Microfracture (CAIS)

A Randomised Clinical Trial Comparing a Novel Single-stage Autologous Cartilage Implantation System to Conventional Microfracture for Repair of Articular Cartilage Defects in the Knee

Sponsor: Singapore General Hospital

Conditions Osteochondritis Dissecans Other Articular Cartilage Disorders

Interventions Cartilage Autograft Implantation System (CAIS) Microfracture

Updated 5 times since 2017 Last updated: Mar 20, 2012 Started: Jan 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Osteochondritis Dissecans and Other Articular Cartilage Disorders and is currently ongoing. Singapore General Hospital leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Singapore General Hospital

Data source: Singapore General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore